Universe Pharmaceuticals (UPC) Change in Accured Expenses (2021 - 2024)
Historic Change in Accured Expenses for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $262.6 million.
- Universe Pharmaceuticals' Change in Accured Expenses fell 9992.56% to $262.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.6 million, marking a year-over-year decrease of 9992.56%. This contributed to the annual value of $262.6 million for FY2025, which is 9992.56% down from last year.
- Latest data reveals that Universe Pharmaceuticals reported Change in Accured Expenses of $262.6 million as of Q3 2025, which was down 9992.56% from $352.9 billion recorded in Q3 2024.
- In the past 5 years, Universe Pharmaceuticals' Change in Accured Expenses ranged from a high of $352.9 billion in Q3 2024 and a low of $444319.0 during Q3 2021
- For the 5-year period, Universe Pharmaceuticals' Change in Accured Expenses averaged around $44.1 billion, with its median value being $2.6 million (2022).
- In the last 5 years, Universe Pharmaceuticals' Change in Accured Expenses tumbled by 9999.99% in 2021 and then surged by 1301200737.33% in 2024.
- Over the past 5 years, Universe Pharmaceuticals' Change in Accured Expenses (Quarter) stood at $444319.0 in 2021, then skyrocketed by 471.52% to $2.5 million in 2022, then rose by 6.79% to $2.7 million in 2023, then skyrocketed by 13012007.37% to $352.9 billion in 2024, then plummeted by 99.93% to $262.6 million in 2025.
- Its Change in Accured Expenses was $262.6 million in Q3 2025, compared to $352.9 billion in Q3 2024 and $2.7 million in Q1 2024.